MILK THISTLE (SILYBUM MARIANUM): A VALUABLE MEDICINAL PLANT WITH SEVERAL THERAPEUTIC PURPOSES
DOI:
https://doi.org/10.15414/jmbfs.2020.9.4.836-843Keywords:
Silybum marianum, silymarin, flavonolignans, pharmacological propertiesAbstract
This review provides a systematic and in-depth overview of the promise and potential of milk thistle (Silybum marianum) as an interesting alternative nutraceutical preparation for pharmaceutical and medicinal applications. Moreover, it aims to summarize and update the existing evidence of extract of milk thistle in the treatment of various diseases by in vitro, in vivo, and clinical studies, and special care is paid to the action mechanisms. The main active component of milk thistle, collectively known as silymarin, consists of a mixture of flavonolignans and flavonoid taxifolin. Silymarin acts as a hepatoprotective, anticancer, anti-inflammatory, immunomodulatory, neuroprotective and lactogenic agent. Precise mechanisms of silymarin action still needs investigations and molecular/genetic background of silymarin synthesis is crucial to be elucidated for reinforcement of the therapeutical potential of the plant by breeding.Downloads
Download data is not yet available.
Downloads
Published
2020-02-03
How to Cite
Valková, V., Ďúranová, H., Bilčíková, J., & Habán, M. (2020). MILK THISTLE (SILYBUM MARIANUM): A VALUABLE MEDICINAL PLANT WITH SEVERAL THERAPEUTIC PURPOSES . Journal of Microbiology, Biotechnology and Food Sciences, 9(4), 836–843. https://doi.org/10.15414/jmbfs.2020.9.4.836-843
Issue
Section
Biotechnology
License
Copyright (c) 2020 Veronika Valková, Hana Ďúranová, Jana BilÄÃková, Miroslav Habán

This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Journal of Microbiology, Biotechnology and Food Sciences are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).